ELMSFORD, N.Y., May 14, 2014 /PRNewswire/ -- BioScrip, Inc.
(NASDAQ: BIOS) today announced that at BioScrip's 2014 Annual
Meeting held on May 8, 2014, its
stockholders voted to elect new independent director Yon Y. Jorden, expanding the size of the Board
of Directors from nine to ten members, nine of whom are independent
and all of whom are elected annually.
Ms. Jorden has more than a decade of leadership experience in
health care services and has served as Chief Financial Officer for
several publicly-traded health care companies over her career,
including AdvancePCS, Oxford Health Plans, Inc. and Wellpoint,
Inc. She also has additional expertise across the technology
and manufacturing industries. Throughout her career, Ms. Jorden has
focused on complex financial transactions, including initial public
offerings and mergers and acquisitions, which will bring additional
valuable perspective to the BioScrip Board. Ms. Jorden will serve
on BioScrip's Audit Committee and Management Development and
Compensation Committee.
"Yon's extensive public company Board experience, strong
financial background and deep knowledge of healthcare will add
considerable value to BioScrip's execution of its ongoing strategic
priorities," said Rick Smith,
President and Chief Executive Officer of BioScrip. "We believe
BioScrip is a dynamic company with strong growth potential in the
infusion industry. Since the beginning of the year, we have
welcomed two highly qualified independent directors to our Board,
and we look forward to building on our recent success as we benefit
from Yon's perspective and expertise."
Ms. Jorden is a National Association of Corporate Directors
(NACD) Board Leadership Fellow and currently serves on the board of
directors of Methodist Health System, a Texas-based not-for-profit hospital system,
and Maxwell Technologies, Inc., a publicly-traded manufacturer of
energy storage and power delivery solutions. She previously served
on the board of directors of Magnetek, Inc. and U.S. Oncology.
Caldwell Partners assisted BioScrip's Board with its director
search process.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion and
home care solutions. BioScrip partners with physicians, hospital
systems, healthcare payors, and pharmaceutical manufacturers to
provide patients access to post-acute care services. BioScrip
operates with a commitment to bring customer-focused pharmacy and
related healthcare infusion therapy services into the home or
alternate- site setting. By collaborating with the full spectrum of
healthcare professionals and the patient, BioScrip provides
cost-effective care that is driven by quality, customer service,
and values that promote positive outcomes and an enhanced quality
of life for those it serves. BioScrip provides its infusion and
home care services from over 80 locations across 29 states.
Contact:
Hai Tran, Chief Financial
Officer
BioScrip
952-979-3768
SOURCE BioScrip, Inc.